Mestag Therapeutics

📍 London, United Kingdom🗓 Founded 2020👥 55 employees💰 Last funded Feb 2020
Biotechnology Research🌐 mestagtherapeutics.com
Website LinkedIn
Mestag focuses on fibroblast-immune interactions to develop innovative new treatments for inflammatory disease and cancer. Through our unique understanding of fibroblast immunology, we are advancing a pipeline of first-in-class antibody programs and targets for new treatments. Backed by committed leading global investors, world-class founders and a highly experienced leadership team, Mestag offers an exciting, diverse and balanced place to work, with competitive benefits, generous vacation time and the room to grow and develop your career.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Mestag Therapeutics?
Mestag Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Mestag Therapeutics last raise funding?
The most recent investment in Mestag Therapeutics recorded on gritt.io was in February 2020.
When was Mestag Therapeutics founded?
Mestag Therapeutics was founded in 2020.
What industry is Mestag Therapeutics in?
Mestag Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Mestag Therapeutics based?
Mestag Therapeutics is headquartered in London, United Kingdom.